CONMED CORPORATION (CNMD) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
CONMED CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $23,071,000.00Amortization → Operating adjustments reconciliation: $14,967,000.00Accrued compensation and benefits → Operating adjustments reconciliation: $9,447,000.00Stock-based compensation → Operating adjustments reconciliation: $5,230,000.00Depreciation → Operating adjustments reconciliation: $4,079,000.00Deferred income taxes → Operating adjustments reconciliation: $2,148,000.00Amortization of deferred debt issuance costs → Operating adjustments reconciliation: $1,054,000.00Other assets → Operating adjustments reconciliation: $532,000.00Operating adjustments reconciliation → Net cash from operating activities: $14,024,000.00Operating adjustments reconciliation → Accounts receivable: $11,351,000.00Operating adjustments reconciliation → Accounts payable: $4,248,000.00Operating adjustments reconciliation → Other liabilities: $4,092,000.00Operating adjustments reconciliation → Remaining operating cash flows, net (calculated): $2,193,000.00Operating adjustments reconciliation → Inventories: $1,437,000.00Operating adjustments reconciliation → Non-cash adjustments to fair value of contingent consideration liability: $112,000.00Remaining investing cash flows, net (calculated) → investing reconciliation: $14,500,000.00investing reconciliation → Net cash from investing activities: $11,566,000.00investing reconciliation → Purchases of property, plant and equipment: $2,934,000.00Net cash used in financing activities → financing reconciliation: $46,234,000.00Proceeds from term loan → financing reconciliation: $450,000,000.00Proceeds from revolving line of credit → financing reconciliation: $415,000,000.00Other, net → financing reconciliation: $182,000.00financing reconciliation → Payments to repurchase convertible notes: $637,176,000.00financing reconciliation → Payments on revolving line of credit: $247,000,000.00financing reconciliation → Payments related to contingent consideration: $17,489,000.00financing reconciliation → Repurchases of common stock: $6,204,000.00financing reconciliation → Payments related to debt issuance costs: $3,547,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $35,030,000.00Net cash from operating activities → Cash sources and uses: $37,095,000.00Net cash from investing activities → Cash sources and uses: $11,566,000.00Cash sources and uses → Exchange-rate effect: $129,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $37,328,000.00Cash sources and uses → Net cash used in financing activities: $46,234,000.00Net income: $23,071,000.00Net income+$23.07 MDepreciation: $4,079,000.00Depreciation expense+$4.08 MAmortization of deferred debt issuance costs: $1,054,000.00Debt issuance cost amortization+$1.05 MAmortization: $14,967,000.00Deferred charges amortization+$14.97 MStock-based compensation: $5,230,000.00Stock-based compensation+$5.23 MDeferred income taxes: $2,148,000.00Deferred income taxes+$2.15 MNon-cash adjustments to fair value of contingent consideration liability: -$112,000.00Contingent consideration change−$112.00 KAccounts receivable: -$11,351,000.00Accounts receivable−$11.35 MInventories: -$1,437,000.00Inventories−$1.44 MAccounts payable: -$4,248,000.00Accounts payable−$4.25 MAccrued compensation and benefits: $9,447,000.00Accrued compensation+$9.45 MOther assets: $532,000.00Other operating assets+$532.00 KOther liabilities: -$4,092,000.00Other operating liabilities−$4.09 MRemaining operating cash flows, net (calculated): -$2,193,000.00Remaining operating (calculated)−$2.19 MNet cash from operating activities: $37,095,000.00Operating cash+$37.10 MOperating adjustments reconciliation: $37,457,000.00Payments on term loan: $0.00Proceeds from term loan: $450,000,000.00Senior debt issued+$450.00 MPayments on revolving line of credit: -$247,000,000.00Credit line repayments−$247.00 MProceeds from revolving line of credit: $415,000,000.00Credit line borrowings+$415.00 MRepurchases of common stock: -$6,204,000.00Common stock repurchases−$6.20 MPayments to repurchase convertible notes: -$637,176,000.00Convertible debt repaid−$637.18 MPayments related to contingent consideration: -$17,489,000.00Contingent consideration paid−$17.49 MPayments related to debt issuance costs: -$3,547,000.00Debt issuance costs−$3.55 MDividends paid on common stock: $0.00Other, net: $182,000.00Other financing, net+$182.00 KNet cash used in financing activities: -$46,234,000.00. Cash required to fund net payments.Financing cash−$46.23 Mfinancing reconciliation: $911,416,000.00Purchases of property, plant and equipment: -$2,934,000.00PP&E purchases−$2.93 MOther: -$0.00Remaining investing cash flows, net (calculated): $14,500,000.00Remaining investing (calculated)+$14.50 MNet cash from investing activities: $11,566,000.00Investing cash+$11.57 Minvesting reconciliation: $14,500,000.00Cash sources and uses: $83,691,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $35,030,000.00Beginning cash$35.03 MEnding cash: Cash, cash equivalents, and restricted cash: $37,328,000.00Ending cash$37.33 MExchange-rate effect: -$129,000.00FX effect−$129.00 KCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$34.16 MOperating cash − cash spent on PP&ECash flow / Net income1.61×Operating cash flow ÷ net incomeNet cash change+$2.30 MEnding cash − beginning cash
Chart details

CONMED CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
35,030,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
37,095,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Gain on sale of a product line), so Gain on sale of product offerings, net and (Gain) loss on early extinguishment of debt, net cannot be separated for this quarter. It may combine inflows and outflows.
Net income
23,071,000 US dollars
Depreciation
4,079,000 US dollars
Amortization of deferred debt issuance costs
1,054,000 US dollars
Amortization
14,967,000 US dollars
Stock-based compensation
5,230,000 US dollars
Deferred income taxes
2,148,000 US dollars
Non-cash adjustments to fair value of contingent consideration liability
negative 112,000 US dollars
Accounts receivable
negative 11,351,000 US dollars
Inventories
negative 1,437,000 US dollars
Accounts payable
negative 4,248,000 US dollars
Accrued compensation and benefits
9,447,000 US dollars
Other assets
532,000 US dollars
Other liabilities
negative 4,092,000 US dollars
Remaining operating cash flows, net (calculated)
negative 2,193,000 US dollars
Investing activities
11,566,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the investing total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Proceeds from sale of a product line), so Proceeds from sale of product offerings cannot be separated for this quarter. It may combine inflows and outflows.
Purchases of property, plant and equipment
negative 2,934,000 US dollars
Other
0 US dollars
Remaining investing cash flows, net (calculated)
14,500,000 US dollars
Financing activities
negative 46,234,000 US dollars. Net cash used.
Payments on term loan
0 US dollars
Proceeds from term loan
450,000,000 US dollars
Payments on revolving line of credit
negative 247,000,000 US dollars
Proceeds from revolving line of credit
415,000,000 US dollars
Repurchases of common stock
negative 6,204,000 US dollars
Payments to repurchase convertible notes
negative 637,176,000 US dollars
Payments related to contingent consideration
negative 17,489,000 US dollars
Payments related to debt issuance costs
negative 3,547,000 US dollars
Dividends paid on common stock
0 US dollars
Other, net
182,000 US dollars
Operating adjustment reconciliation
37,457,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
911,416,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing displayed reconciliation
14,500,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
Exchange-rate effect
negative 129,000 US dollars
Ending cash on Jun 30, 2026
37,328,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
83,691,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
2,298,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.61×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
37,095,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
2,934,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
34,161,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $14.02M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 37,095,000 US dollars minus 2,934,000 US dollars equals 34,161,000 US dollars.
CONMED CORPORATION (CNMD) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!